Igm Antibody To Rbd-Spike?

Spike-RBD-Fc

fc-sars2-rbd 50 µg Ask for price

Anti-Smooth Laboratories manufactures the igm antibody to rbd-spike? reagents distributed by Genprice. The Igm Antibody To Rbd-Spike? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Igm products are available in stock. Specificity: Igm Category: Antibody Group: To Rbd-Spike?

Anti-Spike-RBD mAb

5mg Ask for price
Description: Anti-Spike-RBD mAb

Anti-Spike-RBD-Antibody(R15-F7)

N/A
EUR 157.5
Description: N/A

SARS-CoV-2-Spike-RBD-Antibody

N/A
EUR 346.5
Description: N/A

SARS Spike RBD Recombinant Protein

0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

2019-nCoV Spike protein RBD

10 ug
EUR 192
Description: 2019-nCoV Spike protein RBD (His-tag)

2019-nCoV Spike protein RBD

20 ug
EUR 361
Description: 2019-nCoV Spike protein RBD (His-tag)

2019-nCoV Spike protein RBD

50 ug
EUR 551
Description: 2019-nCoV Spike protein RBD (His-tag)

To Rbd-Spike? information

SARS-CoV-2 Spike RBD protein antibody pair 1

CSB-EAP33245 1 pair
EUR 900
Description: This is a set of capture antibody and HRP-conjugated antbody for quantitative detection of SARS-CoV-2 Spike RBD protein for through solid phase sandwich ELISA.

SARS CoV-2 IgM Spike S1 (CoV-2 IgM S1) Antibody

abx137721-100tests 100 tests
EUR 225

SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin)

9087-biotin-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin)

9087-biotin-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-COV-2 Spike RBD Polyclonal Antibody (2019-nCoV)

E-AB-V1006-100uL 100uL
EUR 415
Description: Unconjugated

SARS-COV-2 Spike RBD Polyclonal Antibody (2019-nCoV)

E-AB-V1006-50uL 50uL
EUR 250
Description: Unconjugated

SARS-COV-2 Spike RBD Polyclonal Antibody (2019-nCoV)

E-AB-V1006-each each Ask for price
Description: Unconjugated

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5)

MAB12443-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (CE5)

MAB12443-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)

MAB12444-100 0.1
EUR 447.79
Description: Purified monoclonal antibody specific for SARS-CoV-2. Antibody is neutralising against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV.

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (DH6)

MAB12444-500 0.5
EUR 1344.64
Description: Purified monoclonal antibody specific for SARS-CoV-2. Antibody is neutralising against SARS-CoV-2, but not against SARS-CoV-1 or MERS-CoV.

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (FG11)

MAB12445-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S1) RBD Antibody (FG11)

MAB12445-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody

Human Anti-SARS CoV 2 Spike RBD Antibody(neutralization)

E2S209907 100ul
EUR 595
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Chicken Anti-SARS-CoV-2 Spike RBD Polyclonal antibody

CABT-CS140 1 mg
EUR 630
Description: Chicken

SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B5]

SD9431-002mg 0.02 mg
EUR 253.22
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike RBD Antibody [T4P3-B5]

SD9431-01mg 0.1 mg
EUR 723.62
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).